Literature DB >> 3374765

Emery-Dreifuss muscular dystrophy: disease spectrum and differential diagnosis.

T Voit1, O Krogmann, H G Lenard, E Neuen-Jacob, W Wechsler, H H Goebel, G Rahlf, A Lindinger, C Nienaber.   

Abstract

We report six patients with Emery-Dreifuss muscular dystrophy (EDMD) and four patients including one female with EDMD phenotype (EDMDP). This series includes one sporadic case who had previously been reported in this journal under the diagnosis of "rigid spine syndrome" in 1977. Time of observation ranged from three to ten years. Detailed cardiological assessment was performed in all patients, skeletal muscle biopsies were obtained from 9 out of 10 and cardiac muscle biopsies from 2 out of 10 patients. One patient showed evidence of cardiomyopathy in the absence of clinically apparent neuromuscular disease and one sibling of another EDMD patient reportedly had a similar combination of symptoms which, to our knowledge, has not yet been reported. Cardiac involvement was found to consist of four independent, albeit often combined features: 1) impairment of impulse generating cells; 2) conduction defects with atrial preponderance; 3) increased atrial and ventricular heterotopia; and 4) functional impairment of ventricular myocardium. Ventricular involvement as apparent from ventricular heterotopia, abnormal enddiastolic diameter, decrease of contractility and/or morphological evidence of ventricular myocardial disease was found in 7 out of 10 patients and confirmed by myocardial histopathology in two EDMD patients. In one myocardial biopsy extensive accumulations of intermediate filaments were observed, a rare finding, which has not been linked to EDMD before. Skeletal muscle biopsies showed evidence of myopathy throughout but several equivocal features such as fibre type grouping in EDMD and fibre type disproportion in EDMDP were also observed. The variability of clinical manifestation of both cardiac and neuromuscular disease encompassed a broader spectrum than apparent from the literature. The consequences for the inherent differential diagnosis are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3374765     DOI: 10.1055/s-2008-1052404

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  15 in total

1.  Emery-Dreifuss muscular dystrophy in the evaluation of decreased spinal mobility and joint contractures.

Authors:  Kamil Goncu; Rengin Guzel; Fusun Guler-Uysal
Journal:  Clin Rheumatol       Date:  2003-10-21       Impact factor: 2.980

Review 2.  Clinical approach to the diagnostic evaluation of hereditary and acquired neuromuscular diseases.

Authors:  Craig M McDonald
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-08       Impact factor: 1.784

3.  The anaesthetic management of a patient with Emery-Dreifuss muscular dystrophy.

Authors:  V Jensen
Journal:  Can J Anaesth       Date:  1996-09       Impact factor: 5.063

4.  Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy.

Authors:  M Raffaele Di Barletta; E Ricci; G Galluzzi; P Tonali; M Mora; L Morandi; A Romorini; T Voit; K H Orstavik; L Merlini; C Trevisan; V Biancalana; I Housmanowa-Petrusewicz; S Bione; R Ricotti; K Schwartz; G Bonne; D Toniolo
Journal:  Am J Hum Genet       Date:  2000-03-16       Impact factor: 11.025

5.  Cardiovascular Complications of Neuromuscular Disorders.

Authors:  Bhavesh Sachdev; Perry M. Elliott; William J. McKenna
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-04

6.  Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?

Authors:  Jop H van Berlo; Willem G de Voogt; Anneke J van der Kooi; J Peter van Tintelen; Gisèle Bonne; Rabah Ben Yaou; Denis Duboc; Tom Rossenbacker; Hein Heidbüchel; Marianne de Visser; Harry J G M Crijns; Yigal M Pinto
Journal:  J Mol Med (Berl)       Date:  2004-11-13       Impact factor: 4.599

7.  Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy.

Authors:  Lucie Gueneau; Anne T Bertrand; Jean-Philippe Jais; Mustafa A Salih; Tanya Stojkovic; Manfred Wehnert; Maria Hoeltzenbein; Simone Spuler; Shinji Saitoh; Annie Verschueren; Christine Tranchant; Maud Beuvin; Emmanuelle Lacene; Norma B Romero; Simon Heath; Diana Zelenika; Thomas Voit; Bruno Eymard; Rabah Ben Yaou; Gisèle Bonne
Journal:  Am J Hum Genet       Date:  2009-08-27       Impact factor: 11.025

Review 8.  Emery-Dreifuss syndrome.

Authors:  A E Emery
Journal:  J Med Genet       Date:  1989-10       Impact factor: 6.318

9.  Expression of growth associated protein 43 and neural cell adhesion molecule in congenital fibre type disproportion with interstitial myositis.

Authors:  D Heuss; A Engelhardt; H Lochmüller; H Göbel; B Neundörfer
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

10.  Cardiac effects of the c.1583 C→G LMNA mutation in two families with Emery-Dreifuss muscular dystrophy.

Authors:  Li Zhang; Hongrui Shen; Zhe Zhao; Qi Bing; Jing Hu
Journal:  Mol Med Rep       Date:  2015-07-08       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.